Sanatorium profesora Arenbergera

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)2 trials
• Ankylosing spondylitis1 trial
• Hidradenitis suppurativa1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• AbbVie2 trials
• Novartis Pharma AG1 trial
• Novartis Pharmaceuticals1 trial

Running trials

• Recruiting

  An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment

  NCT04638647· Phase 4· Novartis Pharma AG· Source

• Active, not recruiting

  A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

  NCT03568318· Phase 3· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ankylosing spondylitis1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa

  NCT04179175· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)

  NCT03607422· Phase 3· AbbVie· Source